These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38635031)

  • 1. Vascular mimicry as a facilitator of melanoma brain metastasis.
    Provance OK; Oria VO; Tran TT; Caulfield JI; Zito CR; Aguirre-Ducler A; Schalper KA; Kluger HM; Jilaveanu LB
    Cell Mol Life Sci; 2024 Apr; 81(1):188. PubMed ID: 38635031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of cell surface GD3 ganglioside phenotype is associated with human melanoma brain metastasis.
    Ramos RI; Bustos MA; Wu J; Jones P; Chang SC; Kiyohara E; Tran K; Zhang X; Stern SL; Izraely S; Sagi-Assif O; Witz IP; Davies MA; Mills GB; Kelly DF; Irie RF; Hoon DSB
    Mol Oncol; 2020 Aug; 14(8):1760-1778. PubMed ID: 32358995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the systemic treatment of melanoma brain metastases.
    Glitza Oliva IC; Schvartsman G; Tawbi H
    Ann Oncol; 2018 Jul; 29(7):1509-1520. PubMed ID: 29790899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies.
    Bander ED; Yuan M; Carnevale JA; Reiner AS; Panageas KS; Postow MA; Tabar V; Moss NS
    Cancer; 2021 Jun; 127(12):2062-2073. PubMed ID: 33651913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival of patients with melanoma brain metastases in the era of targeted BRAF and immune checkpoint therapies.
    Sloot S; Chen YA; Zhao X; Weber JL; Benedict JJ; Mulé JJ; Smalley KS; Weber JS; Zager JS; Forsyth PA; Sondak VK; Gibney GT
    Cancer; 2018 Jan; 124(2):297-305. PubMed ID: 29023643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-invasive activity of the Hippo pathway effectors YAP and TAZ in cutaneous melanoma.
    Nallet-Staub F; Marsaud V; Li L; Gilbert C; Dodier S; Bataille V; Sudol M; Herlyn M; Mauviel A
    J Invest Dermatol; 2014 Jan; 134(1):123-132. PubMed ID: 23897276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma.
    Schvartsman G; Ma J; Bassett RL; Haydu LE; Amaria RN; Hwu P; Wong MK; Hwu WJ; Diab A; Patel SP; Davies MA; Hamerschlak N; Tawbi HA; Glitza Oliva IC
    Cancer; 2019 Dec; 125(23):4193-4202. PubMed ID: 31398264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of TEAD4.
    Zhang Y; Bai J; Cheng R; Zhang D; Qiu Z; Liu T; Che N; Dong X; Zhao N; Lin X; Liang X; Li F; Li Y; Sun B; Zhao X
    J Gastroenterol Hepatol; 2022 Apr; 37(4):714-726. PubMed ID: 35062042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities?
    Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF
    Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A distinct pattern of growth and RAC1 signaling in melanoma brain metastasis cells.
    Stejerean-Todoran I; Gimotty PA; Watters A; Brafford P; Krepler C; Godok T; Li H; Bonilla Del Rio Z; Zieseniss A; Katschinski DM; Sertel SM; Rizzoli SO; Garman B; Nathanson KL; Xu X; Chen Q; Oswald JH; Lotem M; Mills GB; Davies MA; Schön MP; Bogeski I; Herlyn M; Vultur A
    Neuro Oncol; 2023 Apr; 25(4):674-686. PubMed ID: 36054930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenome-wide DNA methylation landscape of melanoma progression to brain metastasis reveals aberrations on homeobox D cluster associated with prognosis.
    Marzese DM; Scolyer RA; Huynh JL; Huang SK; Hirose H; Chong KK; Kiyohara E; Wang J; Kawas NP; Donovan NC; Hata K; Wilmott JS; Murali R; Buckland ME; Shivalingam B; Thompson JF; Morton DL; Kelly DF; Hoon DS
    Hum Mol Genet; 2014 Jan; 23(1):226-38. PubMed ID: 24014427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis.
    Lamar JM; Xiao Y; Norton E; Jiang ZG; Gerhard GM; Kooner S; Warren JSA; Hynes RO
    J Biol Chem; 2019 Feb; 294(7):2302-2317. PubMed ID: 30559289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases.
    Weiss SA; Zito C; Tran T; Heishima K; Neumeister V; McGuire J; Adeniran A; Kluger H; Jilaveanu LB
    J Neurooncol; 2021 Mar; 152(1):15-25. PubMed ID: 32974852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor cell vascular mimicry: Novel targeting opportunity in melanoma.
    Hendrix MJ; Seftor EA; Seftor RE; Chao JT; Chien DS; Chu YW
    Pharmacol Ther; 2016 Mar; 159():83-92. PubMed ID: 26808163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.
    Marzese DM; Liu M; Huynh JL; Hirose H; Donovan NC; Huynh KT; Kiyohara E; Chong K; Cheng D; Tanaka R; Wang J; Morton DL; Barkhoudarian G; Kelly DF; Hoon DS
    Pigment Cell Melanoma Res; 2015 Jan; 28(1):82-93. PubMed ID: 25169209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts.
    Orecchia P; Conte R; Balza E; Pietra G; Mingari MC; Carnemolla B
    Oncotarget; 2015 Nov; 6(35):37426-42. PubMed ID: 26460958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developments in therapy for brain metastases in melanoma patients.
    Wilkes JG; Patel A; McClure E; Pina Y; Zager JS
    Expert Opin Pharmacother; 2021 Aug; 22(11):1443-1453. PubMed ID: 33688795
    [No Abstract]   [Full Text] [Related]  

  • 18. Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma.
    Oria VO; Zhang H; Zito CR; Rane CK; Ma XY; Provance OK; Tran TT; Adeniran A; Kluger Y; Sznol M; Bosenberg MW; Kluger HM; Jilaveanu LB
    Cell Mol Life Sci; 2022 Jun; 79(7):377. PubMed ID: 35737114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma brain metastases - Interdisciplinary management recommendations 2020.
    Gutzmer R; Vordermark D; Hassel JC; Krex D; Wendl C; Schadendorf D; Sickmann T; Rieken S; Pukrop T; Höller C; Eigentler TK; Meier F
    Cancer Treat Rev; 2020 Sep; 89():102083. PubMed ID: 32736188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.
    Zhang W; Zhou P; Meng A; Zhang R; Zhou Y
    J Cell Mol Med; 2018 Mar; 22(3):1743-1754. PubMed ID: 29164766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.